wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38292875-E28C15C4-9035-4493-86B0-8D9BEAF09741
Q38292875-E28C15C4-9035-4493-86B0-8D9BEAF09741
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38292875-E28C15C4-9035-4493-86B0-8D9BEAF09741
The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer.
P2860
Q38292875-E28C15C4-9035-4493-86B0-8D9BEAF09741
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38292875-E28C15C4-9035-4493-86B0-8D9BEAF09741
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
36003510f9d64780f910f754e876dbce43c15f17
P2860
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.